Key facts
- It has raised $7.0M.
- Notable investors include Techstars, MassChallenge, MedTech Innovator, Texas Medical Center, Innovation Works — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for CranioSense
- ·The full record, as it builds
Funding rounds
No funding rounds for CranioSense are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CranioSense
Manufacturer of medical devices intended to unlock the hidden parameters of brain health by enabling on-demand neurological insight. The company offers noninvasive medical devices for initial diagnosis and continuous monitoring of intracranial hypertension, the point at which ICP becomes clinically unacceptable, enabling healthcare professionals with treatment across the neurological care spectrum.
- Sector
- Healthcare
- HQ
- Bedford, MA, United States
- Founded
- 2022
- Employees
- 6
- Website
- craniosense.com/
- Ownership
- Privately Held (backing)
CranioSense doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CranioSense shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CranioSense in its N-PORT filings yet. We sweep new filings monthly.